Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Transplants With Unlicensed Preserved Cord Blood

    ... centers Patients who are enrolled on another IND protocol to access the unlicensed CBU(s) Patients whose selected ...

    Clinical Trial last updated 05/09/2016 - 3:47pm.

  2. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    ... will not be eligible for the transplant phase of the protocol , and will thus be taken off study. Patients who are hepatitis ... from the study, but will continue to be managed on this protocol for all transplant-related care and complications. Inadequate stem ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.

  3. Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome

    ... associated with conventional UCBT. This research protocol is therefore designed to evaluate the safety and effectiveness of ...

    Clinical Trial last updated 04/25/2016 - 2:18pm.

  4. Even "Moderate" Dose Cyclophosphamide for Severe Aplastic Anemia Is Associated with Significant Toxicities and Does Not Prevent Relapse and Clonal Evolution

    ... is available. Both in this study and the companion protocol by the same group (investigating cyclophosphamide 60mg/kg plus ...

    Research Review last updated 05/02/2016 - 9:23am.

  5. Casey O’Connell, MD

    ... O’Connell has also created a hematology tissue banking protocol at USC which will foster an integrative approach to the ...

    Page last updated 04/18/2012 - 1:47pm.

  6. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... from MDS, who are not eligible for transplantation under protocol IRB 08-008. Chronic myelomonocytic leukemia: CMML-1 and ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  7. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    ... for transplantation and/or unable to enroll onto protocol IRB 08-008. Chronic myelomonocytic leukemia: CMML-1 and ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  8. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... has elapsed between last treatment and enrollment on protocol Eastern Cooperative Oncology Group (ECOG) performance status ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  9. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)

    ... is able to adhere to the study visit schedule and other protocol requirements, including follow-up for response assessments The ...

    Clinical Trial last updated 06/06/2016 - 2:11pm.

  10. Total Marrow Irradiation for Refractory Acute Leukemia

    ... should continue as medically indicated during the protocol . Have acceptable organ function within 14 days of study ...

    Clinical Trial last updated 05/02/2016 - 9:22am.